Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection
Clinical trial NCT04818216 · COMPLETED
Trial details
- NCT number
- NCT04818216
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-11
- Primary completion
- 2021-12-09
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.